Exclusive: Dicerna CEO Discusses Financials And Institutional Investors
Exclusive: Dicerna CEO Talks Products, Partnerships And Stock Performance
Exclusive: Dicerna CEO Explains RNA Interference And How It's Used To Treat Rare Genetic Diseases
Maxim Analyst Issues Update On Tekmira's Ebola Research Development